×
STERIS Cash on Hand 2010-2025 | STE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
STERIS cash on hand for the quarter ending March 31, 2025 was
$0.172B
, a
17.06% decline
year-over-year.
STERIS cash on hand for 2025 was
$0.172B
, a
17.06% decline
from 2024.
STERIS cash on hand for 2024 was
$0.207B
, a
0.64% decline
from 2023.
STERIS cash on hand for 2023 was
$0.208B
, a
40.18% decline
from 2022.
View More
STERIS Cash on Hand 2010-2025 | STE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
STERIS cash on hand for 2025 was
$0.172B
, a
17.06% decline
from 2024.
STERIS cash on hand for 2024 was
$0.207B
, a
0.64% decline
from 2023.
STERIS cash on hand for 2023 was
$0.208B
, a
40.18% decline
from 2022.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$180.2B
Intuitive Surgical (ISRG)
$179.4B
Edwards Lifesciences (EW)
$47.6B
IDEXX Laboratories (IDXX)
$46B
Alcon (ALC)
$44B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$32.6B
Mettler-Toledo (MTD)
$26.3B
Waters (WAT)
$17.8B
SONOVA HOLDING (SONVY)
$16.4B
Hologic (HOLX)
$14.5B
Sysmex ADR (SSMXY)
$10.4B
Penumbra (PEN)
$9.8B
Masimo (MASI)
$8.5B
Globus Medical (GMED)
$7.2B
Glaukos (GKOS)
$5.4B
Teleflex (TFX)
$5B
Integer Holdings (ITGR)
$3.8B
TransMedics (TMDX)
$3.6B
PROCEPT BioRobotics (PRCT)
$2.8B
LivaNova (LIVN)
$2.4B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.9B
Veracyte (VCYT)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Tandem Diabetes Care (TNDM)
$1.1B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$991M